Ningxiang pig-derived Enterococcus hirae protects against E. coli-induced gut dysbiosis and inflammation via acetate/propionate-MyD88-NF-κB axis in piglets
Open Access
- 6 January 2026
- journal article
- research article
- Published by Springer Nature in Microbiome
- Vol. 14 (1)
Abstract
Background: Intestinal inflammation, often driven by microbial dysbiosis and infections, remains a significant health challenge with limited effective treatments. Identifying probiotic strains with anti-inflammatory properties and elucidating their mechanisms is essential for developing novel therapeutic strategies. This study investigates the molecular mechanisms by which E. hirae —a lactic acid bacterium (LAB) isolated from Ningxiang piglets with low diarrhea incidence—alleviates E. coli -induced intestinal inflammation. Results: In the present study, comparative analysis showed that Ningxiang piglets exhibited a significantly lower incidence of diarrhea and reduced E. coli abundance compared to Yorkshire piglets. Notably, E. hirae was more abundant in Ningxiang piglets and correlated with elevated secretory IgA levels. Additionally, in vitro antagonism assays found that E. hirae effectively inhibited E. coli growth. In vivo supplementation of E. hirae in E. coli -infected piglets restored intestinal microbial balance, increased levels of short-chain fatty acids (SCFAs) such as acetate and propionate, and mitigated E. coli colonization. Further analyses suggested that acetate and propionate downregulated the MyD88/NF-κB signaling pathway, thereby reducing pro-inflammatory cytokine expression. Molecular docking and MyD88 − / − experiments verified that MyD88 is involved in SCFA-mediated protection against E. coli -induced inflammation. Furthermore, analyses of public human datasets revealed that Crohn’s disease patients exhibited a similar reduction in SCFA levels and MyD88–NF-κB pathway activation, suggesting potential clinical relevance. Conclusion: Token together, our results reveal that Ningxiang pig-derived E. hirae alleviates E. coli -induced gut dysbiosis and inflammation potentially through the acetate/propionate–MyD88–NF-κB axis. This work provides mechanistic insights for further exploration of probiotic and postbiotic approaches against bacterial-induced intestinal inflammation.Keywords
This publication has 66 references indexed in Scilit:
- Elevated SPARC Disrupts the Intestinal Barrier Integrity in Crohn's Disease by Interacting with OTUD4 and Activating the MYD88/NF‐κB PathwayAdvanced Science, 2025
- Ningxiang pig-derived Enterococcus hirae HNAU0516 ameliorates postweaning diarrhoea by promoting intestinal health and modulating the gut microbiota in pigletsAnimal, 2024
- Bacterial peptidoglycan serves as a critical modulator of the gut-immune-brain axis in DrosophilaBrain, Behavior, and Immunity, 2024
- Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A reviewBiomedicine & Pharmacotherapy, 2023
- Therapeutic effect of Brucea javanica oil emulsion on experimental Crohn’s disease in rats: Involvement of TLR4/ NF-κB signaling pathwayBiomedicine & Pharmacotherapy, 2019
- Loss of Response to Vedolizumab and Ability of Dose Intensification to Restore Response in Patients With Crohn’s Disease or Ulcerative Colitis: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2019
- Immune-Microbiota Interactions: Dysbiosis as a Global Health IssueCurrent Allergy and Asthma Reports, 2016
- Significance of Short Chain Fatty Acid Transport by Members of the Monocarboxylate Transporter Family (MCT)Neurochemical Research, 2012
- The SLC16A Family of Monocarboxylate Transporters (MCTs)—Physiology and Function in Cellular Metabolism, pH Homeostasis, and Fluid Transport2012
- Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohnʼs diseaseInflammatory Bowel Diseases, 2009